company background image
SN. logo

Smith & Nephew LSE:SN. Stock Report

Last Price

UK£11.37

Market Cap

UK£9.9b

7D

-1.8%

1Y

17.9%

Updated

07 Oct, 2024

Data

Company Financials +

Smith & Nephew plc

LSE:SN. Stock Report

Market Cap: UK£9.9b

SN. Stock Overview

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.

About the company

SN. fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health4/6
Dividends3/6

Rewards

Trading at 39.4% below our estimate of its fair value
Earnings are forecast to grow 22.71% per year

Risk Analysis

Dividend of 2.6% is not well covered by earnings or free cash flows
Has a high level of debt
Large one-off items impacting financial results

Smith & Nephew plc Competitors

NIOX Group

AIM:NIOX

UK£281.6m

ConvaTec Group

LSE:CTEC

UK£4.6b

EKF Diagnostics Holdings

AIM:EKF

UK£137.9m

Mediclinic International

LSE:MDC

UK£3.7b

Price History & Performance

Summary of all time highs, changes and price drops for Smith & Nephew
Historical stock prices
Current Share PriceUK£11.37
52 Week HighUK£12.45
52 Week LowUK£8.87
Beta0.62
11 Month Change-5.13%
3 Month Change5.47%
1 Year Change17.92%
33 Year Change-9.58%
5 Year Change-38.89%
Change since IPO5,636.40%

Recent News & Updates

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Sep 25
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08
Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Recent updates

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Sep 25
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08
Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Jun 16
Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Apr 16
Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Mar 16
Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Feb 21
Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Dec 15
Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Nov 30
Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Oct 29
Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19
Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17
Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11
Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

May 09
Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Apr 09
Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Feb 09
Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Nov 21
We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11
These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28
There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Apr 29
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Shareholder Returns

SN.GB Medical EquipmentGB Market
7D-1.8%-3.0%-0.3%
1Y17.9%10.2%9.3%

Return vs Industry: SN. exceeded the UK Medical Equipment industry which returned 10.2% over the past year.

Return vs Market: SN. exceeded the UK Market which returned 9.3% over the past year.

Price Volatility

Is SN.'s price volatile compared to industry and market?
SN. volatility
SN. Average Weekly Movement2.9%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.5%
10% least volatile stocks in GB Market2.6%

Stable Share Price: SN. has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: SN.'s weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
185618,000Deepak Nathwww.smith-nephew.com

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Smith & Nephew plc Fundamentals Summary

How do Smith & Nephew's earnings and revenue compare to its market cap?
SN. fundamental statistics
Market capUK£9.91b
Earnings (TTM)UK£233.46m
Revenue (TTM)UK£4.32b

42.5x

P/E Ratio

2.3x

P/S Ratio

Is SN. overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SN. income statement (TTM)
RevenueUS$5.64b
Cost of RevenueUS$1.67b
Gross ProfitUS$3.97b
Other ExpensesUS$3.66b
EarningsUS$305.00m

Last Reported Earnings

Jun 29, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.35
Gross Margin70.33%
Net Profit Margin5.41%
Debt/Equity Ratio66.7%

How did SN. perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

107%

Payout Ratio